Don’t Let the Pandemic Eclipse the Opioid Epidemic
WASHINGTON, D.C., UNITED STATES, May 4, 2020 /EINPresswire.com/ — As the world adapts to this new normal, experts are becoming increasingly concerned that the coronavrirus pandemic will undermine earnest legislative and enforcement efforts designed to thwart the opioid crisis.
In response, the DEA has published guidance concerning telemedicine, suspicious orders and due diligence, prescriptions, and record and reports, alongside a blitz of other COVD-19-related support.
Don’t be left in the dark.
It is more imperative than ever to join us at our 3rd Annual Summit on Controlled Substances on July 21-22 at the Washington Hilton in Washington, DC. This collaborative and interactive forum is a must-attend conference where compliance, legal, and regulatory professionals will gather with peers, discuss novel challenges post COVID-19, and walk away with tailored solutions for overcoming these new and relentless hindrances.
Join representatives from DEA, FDA, and DOJ, as well as other industry authorities who will provide a forward thinking analysis of the existing regulations, proposed reformations, and real-world guidance that can be proximately executed.
We look forward to seeing you in-person or virtually this Summer.
American Conference Institute's Global Series of Life Sciences conferences bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostics, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Visit https://www.americanconference.com/conferences/life-sciences/ for full list of upcoming events in 2020.
Source: EIN Presswire